| BMI | body mass index |
| CA | cancer antigen |
| CC | case control |
| CEBM | Centre for Evidence-Based Medicine |
| CEE | conjugated equine estrogen |
| CI | confidence interval |
| CS | cohort study |
| DRSP | drospirenone |
| E2 | estradiol |
| EC | endometrial cancer |
| EMBASE | excerpta medica database |
| FIGO | International Federation of Gynecology and Obstetrics (Fédération Internationale de Gynécologie et d’Obstétrique) |
| HR | hazard ratio |
| HT | hormone therapy |
| ICTRP | International Clinical Trials Registry Platform |
| IQR | interquartile range |
| LN | lymph node |
| MPA | medroxyprogesterone acetate |
| NRS | non-randomized study |
| OR | odds ratio |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| RCT | randomised controlled trial |
| RR | relative risk |
| RT | radiotherapy |